Literature DB >> 11522670

The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria.

C Bingham1, S Ellard, A J Nicholls, C A Pennock, J Allen, A J James, S C Satchell, M B Salzmann, A T Hattersley.   

Abstract

Hepatocyte nuclear factor-1alpha (HNF-1alpha) mutations are the most common cause of maturity-onset diabetes of the young. HNF-1alpha homozygous knockout mice exhibit a renal Fanconi syndrome with glucosuria and generalized aminoaciduria in addition to diabetes. We investigated glucosuria and aminoaciduria in patients with HNF-1alpha mutations. Sixteen amino acids were measured in urine samples from patients with HNF-1alpha mutations, age-matched nondiabetic control subjects, and age-matched type 1 diabetic patients, type 2 diabetic patients, and patients with diabetes and chronic renal failure. The HNF-1alpha patients had glucosuria at lower glycemic control (as shown by HbA1c) than type 1 and type 2 diabetic patients, consistent with a lower renal glucose threshold. The HNF-1alpha patients had a generalized aminoaciduria with elevated levels of 14 of 16 amino acids and an increased mean Z score for all amino acids compared with control subjects (0.66 vs. 0.00; P < 0.0005). Generalized aminoaciduria was also present in type 1 diabetic (Z score, 0.80; P < 0.0001), type 2 diabetic (Z score, 0.71; P < 0.0002), and chronic renal failure (Z score, 0.65; P < 0.01) patients. Aminoaciduria was not associated with microalbuminuria or proteinuria but was associated with glucosuria (1.00 glucosuria vs. 0.19 no glucosuria; P = 0.002). In type 1 diabetic patients, urine samples taken on the same day showed significantly more aminoaciduria when glucosuria was present compared with when it was absent (P < 0.01). In conclusion, HNF-1alpha mutation carriers have a mutation-specific defect of proximal tubular glucose transport, resulting in increased glucosuria. In contrast, the generalized aminoaciduria seen in patients with HNF-1alpha mutations is a general feature of patients with diabetes and glucosuria. Glucose may depolarize and dissipate the electrical gradient of the sodium-dependent amino acid transporters in the proximal renal tubule, causing a reduction in amino acid resorption.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522670     DOI: 10.2337/diabetes.50.9.2047

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

Review 1.  The role of pancreatic imaging in monogenic diabetes mellitus.

Authors:  Ingfrid S Haldorsen; Helge Ræder; Mette Vesterhus; Anders Molven; Pål R Njølstad
Journal:  Nat Rev Endocrinol       Date:  2011-11-29       Impact factor: 43.330

2.  Metabolomics identifies novel Hnf1alpha-dependent physiological pathways in vivo.

Authors:  Jessica A Bonzo; Andrew D Patterson; Kristopher W Krausz; Frank J Gonzalez
Journal:  Mol Endocrinol       Date:  2010-10-13

3.  Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.

Authors:  Katharine R Owen; Gaya Thanabalasingham; Timothy J James; Fredrik Karpe; Andrew J Farmer; Mark I McCarthy; Anna L Gloyn
Journal:  Diabetes Care       Date:  2010-08-19       Impact factor: 17.152

4.  Evaluation of Apolipoprotein M Serum Concentration as a Biomarker of HNF-1alpha MODY.

Authors:  Jan Skupien; Grzegorz Kepka; Sylwia Gorczynska-Kosiorz; Anna Gebska; Tomasz Klupa; Krzysztof Wanic; Natalia Nowak; Maciej Borowiec; Jacek Sieradzki; Maciej T Malecki
Journal:  Rev Diabet Stud       Date:  2008-02-10

Review 5.  Monogenic diabetes and pregnancy.

Authors:  Rinki Murphy
Journal:  Obstet Med       Date:  2015-06-29

6.  Blood pressure and uric acid in diabetes mellitus.

Authors:  Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-03-26       Impact factor: 3.738

7.  Mutations in HNF1A result in marked alterations of plasma glycan profile.

Authors:  Gaya Thanabalasingham; Jennifer E Huffman; Jayesh J Kattla; Mislav Novokmet; Igor Rudan; Anna L Gloyn; Caroline Hayward; Barbara Adamczyk; Rebecca M Reynolds; Ana Muzinic; Neelam Hassanali; Maja Pucic; Amanda J Bennett; Abdelkader Essafi; Ozren Polasek; Saima A Mughal; Irma Redzic; Dragan Primorac; Lina Zgaga; Ivana Kolcic; Torben Hansen; Daniela Gasperikova; Erling Tjora; Mark W J Strachan; Trine Nielsen; Juraj Stanik; Iwar Klimes; Oluf B Pedersen; Pål R Njølstad; Sarah H Wild; Ulf Gyllensten; Olga Gornik; James F Wilson; Nicholas D Hastie; Harry Campbell; Mark I McCarthy; Pauline M Rudd; Katharine R Owen; Gordan Lauc; Alan F Wright
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

8.  A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control.

Authors:  Noha A Yousri; Dennis O Mook-Kanamori; Mohammed M El-Din Selim; Ahmed H Takiddin; Hala Al-Homsi; Khoulood A S Al-Mahmoud; Edward D Karoly; Jan Krumsiek; Kieu Trinh Do; Kieu Thinh Do; Ulrich Neumaier; Marjonneke J Mook-Kanamori; Jillian Rowe; Omar M Chidiac; Cindy McKeon; Wadha A Al Muftah; Sara Abdul Kader; Gabi Kastenmüller; Karsten Suhre
Journal:  Diabetologia       Date:  2015-06-07       Impact factor: 10.122

9.  Serum uric acid and hypertension in adults: a paradoxical relationship in type 1 diabetes.

Authors:  Petter Bjornstad; R Paul Wadwa; Jeffrey C Sirota; Janet K Snell-Bergeon; Kimberly McFann; Marian Rewers; Christopher J Rivard; Diana Jalal; Michel B Chonchol; Richard J Johnson; David M Maahs
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-03-26       Impact factor: 3.738

10.  Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.

Authors:  Anna L Gloyn; Johan H Faber; Daniel Malmodin; Gaya Thanabalasingham; Francis Lam; Per Magne Ueland; Mark I McCarthy; Katharine R Owen; Dorrit Baunsgaard
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.